Global CRM in Pharma and Biotech Software Market Size study, by Type (Cloud-based, Web-based), by Application (Large Enterprises, SMEs) and Regional Forecasts 2018-2025


Report ID : RC-43883 Category : Information And Communication Technology
Published Date : Jun-19 Pages : 200 Format : PDF
Global CRM in Pharma and Biotech Software Market to reach USD XX million by 2025. 

Global CRM in Pharma and Biotech Software Market valued approximately USD 996.58 million in 2017  is anticipated to grow with a healthy growth rate of more than 11.23% over the forecast period 2018-2025. The CRM in Pharma and Biotech Software Market is continuously growing across the world over the coming years. CRM in Pharma and Biotech Software is a type of CRM software that can help users to manage competitive intelligence and life sciences data. CRM is a business strategy aimed at understanding, anticipating and responding to your customers in a way that grows relationship and satisfies mutual objective. Further, CRM software can deliver several tactical benefits. However, when CRM software is combined with CRM strategy and possibly even a social strategy, it becomes a powerful tool to aid the company?s top objectives. Escalating pharmaceutical and biotech sector, rising need for database management and surging number of patients in hospitals and diagnostic centres are the substantial drivers of the market across the globe. Moreover, increasing disposable income of the individuals and growing health consciousness, which is likely to creating numerous opportunity in the near future. However, high production cost and Lack of Skilled Professionals are the factors which limiting the market growth of CRM in Pharma and Biotech Software during the forecast period. The regional analysis of Global CRM in Pharma and Biotech Software Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. 

The major market player included in this report are:
?	Inova Software
?	Veeva Systems
?	Aurea
?	Oracle Corporation
?	Indegene
?	Ivy
?	Media-Soft 
?	Navicon
?	Pitcher 

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: 

By Type:

?	Cloud-based
?	Web-based

By Application:

?	Large Enterprises
?	SMEs

By Regions:
?	North America
o	U.S.
o	Canada
?	Europe
o	UK
o	Germany
?	Asia Pacific
o	China
o	India
o	Japan
?	Latin America
o	Brazil
o	Mexico
?	Rest of the World

Furthermore, years considered for the study are as follows:

Historical year ? 2015, 2016
Base year ? 2017
Forecast period ? 2018 to 2025

Target Audience of the Global CRM in Pharma and Biotech Software Market in Market Study:

?	Key Consulting Companies & Advisors
?	Large, medium-sized, and small enterprises
?	Venture capitalists
?	Value-Added Resellers (VARs)
?	Third-party knowledge providers
?	Investment bankers
?	Investors
TABLE OF CONTENTS

Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1.	CRM in Pharma and Biotech Software Market, by Type, 2015-2025 (USD Billion)
1.3.2.	CRM in Pharma and Biotech Software Market, by Application, 2015-2025 (USD Billion)
1.3.3.	CRM in Pharma and Biotech Software Market, by Region, 2015-2025 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	CRM in Pharma and Biotech Software Market Definition and Scope 
2.1.	Objective of the Study	
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	CRM in Pharma and Biotech Software Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	CRM in Pharma and Biotech Software Market Industry Analysis
4.1.	Porter?s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter?s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Value Chain Analysis
4.3.1.	Supplier
4.3.2.	Manufacturers/Service Provider
4.3.3.	Distributors
4.3.4.	End-users
4.4.	Key Buying Criteria
4.5.	Regulatory Framework
4.6.	Cost Structure Analysis
4.6.1.	Raw Material Cost Analysis
4.6.2.	Manufacturing Cost Analysis
4.6.3.	Labour Cost Analysis 
4.7.	Investment Vs Adoption Scenario
4.8.	Analyst Recommendation & Conclusion
Chapter 5.	CRM in Pharma and Biotech Software Market, by Type
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Key Market Players
5.4.	CRM in Pharma and Biotech Software Market, Sub Segment Analysis
5.4.1.	Cloud-based
5.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.	Web-based
5.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6.	CRM in Pharma and Biotech Software Market, by Application
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Key Market Players
6.4.	CRM in Pharma and Biotech Software Market, Sub Segment Analysis
6.4.1.	Large Enterprises
6.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.	SMEs
6.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7.	CRM in Pharma and Biotech Software Market, by Regional Analysis
7.1.	CRM in Pharma and Biotech Software Market, Regional Market Snapshot (2015-2025)
7.2.	North America CRM in Pharma and Biotech Software Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2.	Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.	Europe CRM in Pharma and Biotech Software Market  Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.	Germany 
7.3.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.	France 
7.3.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.	Rest of Europe
7.3.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.	Asia CRM in Pharma and Biotech Software Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2.	Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.	Latin America CRM in Pharma and Biotech Software Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2.	Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.	Rest of The World 
7.6.1.	South America
7.6.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.	Middle East and Africa
7.6.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2.	 Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3.	Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	Inova Software
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	 Summary
8.3.1.4.	Recent Developments
8.3.2.	Veeva Systems
8.3.3.	Aurea
8.3.4.	Oracle Corporation
8.3.5.	Indegene
8.3.6.	Ivy
8.3.7.	Media-Soft 
8.3.8.	Navicon
8.3.9.	Pitcher
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Sidebar Menu